Remove Manufacturing Remove Pharmaceutical manufacturing Remove Specialization
article thumbnail

FDA completes inspection of Nexus’ manufacturing facility in US

Pharma Leaders

The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticalspharmaceutical manufacturing facility located in Pleasant Prairie, Wisconsin, US. The inspection will allow the company to commence commercial operations at the three-storey, 84,000ft² manufacturing facility.

article thumbnail

Cleanrooms-on-demand: a more efficient future for pharma?

pharmaphorum

Now, this service-centred model is delivering advantages in the pharmaceutical industry, with costly manufacturing facilities and processes becoming widely available on an on-demand basis. But with a single dedicated cleanroom environment costing around $2.5 Meeting strict standards. Enter cleanrooms-on-demand….

Pharma 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Supply Chain Planning Can Help Pharma Meet All-Time High Drug Supply Demands

PM360

Although the driving factors of the shortage are complex, the bottom line is that drug manufacturers, particularly those that produce generic drugs, can’t afford to stockpile raw materials and products to prepare for shortages due to financial, storage capability, and product expiry limitations.

article thumbnail

Eugia Pharma -Walk-In Interviews for Production/ Warehouse / Quality Assurance/ Quality Control/ Microbiology On 24th Sept’ 2022

Pharma Pathway

Eugia Pharma Specialities Limited is Subsidiary of Aurobindo Pharma Limited, Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Job Description.

Pharma 86
article thumbnail

Novel two-chamber setup could predict HPAPI dustiness

European Pharmaceutical Review

Processes in pharmaceutical manufacturing such as processing, milling, grinding, and mixing, are associated with the generation of dust. The researchers highlighted that the risks of hazard exposure include danger to the health of operators and cross-contaminations during manufacturing.

article thumbnail

Revolutionizing Solid Production: Unleashing Agility in Granulation Systems

PharmaTech

Do you face challenges when it comes to smaller production quantities, more specialization and many product creations. With the help of agile systems pharmaceutical manufacturers can overcome these challenges just as easy. Flexibility is the answer.

article thumbnail

ISPOR 2023: A Focus on Quality

Prognos Health

And as these stakeholders are presented with more and more RWE from pharmaceutical manufacturers, they are asking tough questions to better understand whether to use this evidence when making critical decisions that impact the health of patients.